Key result
In a pilot study of 60 patients undergoing implantable cardioverter-defibrillator insertion, defibrillation threshold testing was found to be unnecessary as no cases required lead repositioning or system modification.
Why the study?
Is avoidance of defibrillation threshold testing at the time of internal defibrillator insertion safe in patients undergoing implantable cardioverter defibrillator implantation?
Observational (n=60)
No
Is avoidance of defibrillation threshold testing at the time of internal defibrillator insertion safe in patients undergoing implantable cardioverter defibrillator implantation?
This review and pilot study explore the safety and necessity of defibrillation threshold testing during ICD implantation to potentially simplify the procedure and reduce morbidity.
May support omitting DFT testing at ICD implant; hypothesis-generating and should not yet change practice.
This article consists of a subject review supported by a short-term pilot study which was conducted prospectively to shed light into the controversial question regarding the necessity of having the defibrillation threshold measured at the time of the implantable cardioverter defibrillator implantation. Answering this question will have an important impact on reducing the well-documented morbidity and mortality, making the operation simpler and cost-effective.
No takes yet. Share an insight, caveat, or question.
Anton Fomenko (2012) conducted an observational in Patients requiring internal defibrillator insertion (n=60). Defibrillation threshold (DFT) testing was evaluated on Need for lead repositioning or ICD system modification. In a pilot study of 60 patients undergoing implantable cardioverter-defibrillator insertion, defibrillation threshold testing was found to be unnecessary as no cases required lead repositioning or system modification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: